These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 8886913)

  • 61. The value of prostate specific antigen (PSA) density and free: total PSA ratio in selecting patients with a normal digital rectal examination and intermediate total PSA levels for further investigation.
    Klingler HC; Woo H; Rosario D; Cutinha PE; Anderson J; Ward AM; Chapple CR
    Br J Urol; 1998 Sep; 82(3):393-7. PubMed ID: 9772877
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Diagnostic value of MRI-based PSA density in predicting transperineal sector-guided prostate biopsy outcomes.
    MacAskill F; Lee SM; Eldred-Evans D; Wulaningsih W; Popert R; Wolfe K; Van Hemelrijck M; Rottenberg G; Liyanage SH; Acher P
    Int Urol Nephrol; 2017 Aug; 49(8):1335-1342. PubMed ID: 28477301
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Usefulness of PSA density and PSA excess in the differential diagnosis between prostate cancer and benign prostatic hypertrophy.
    Diaz F; Morell M; Rojo G
    Int J Biol Markers; 1996; 11(1):12-7. PubMed ID: 8740636
    [TBL] [Abstract][Full Text] [Related]  

  • 64. The significance of the free-to-complexed prostate-specific antigen (PSA) ratio in prostate cancer detection in patients with a PSA level of 4.1-10.0 ng/mL.
    Okegawa T; Kinjo M; Watanabe K; Noda H; Kato M; Miyata A; Murata A; Yoshii M; Nutahara K; Higashihara E
    BJU Int; 2000 Apr; 85(6):708-14. PubMed ID: 10759671
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Proprostate-specific antigen: its usefulness in the era of multiple-core prostate biopsy.
    Miyakubo M; Ito K; Yamamoto T; Takechi H; Ohi M; Suzuki K
    Int J Urol; 2009 Jun; 16(6):561-5. PubMed ID: 19456991
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Prostate specific antigen adjusted for the transition zone volume as an indicator of prostate cancer.
    Maeda H; Arai Y; Ishitoya S; Okubo K; Aoki Y; Okada T
    J Urol; 1997 Dec; 158(6):2193-6. PubMed ID: 9366342
    [TBL] [Abstract][Full Text] [Related]  

  • 67. The use of artificial neural network analysis to improve the predictive accuracy of prostate biopsy in the Japanese population.
    Matsui Y; Utsunomiya N; Ichioka K; Ueda N; Yoshimura K; Terai A; Arai Y
    Jpn J Clin Oncol; 2004 Oct; 34(10):602-7. PubMed ID: 15591458
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Comparison of prostate-specific antigen adjusted for transition zone volume versus prostate-specific antigen density in predicting prostate cancer by transrectal ultrasonography.
    Sung DJ; Cho SB; Kim YH; Oh YW; Lee NJ; Kim JH; Chung KB; Moon DG
    J Ultrasound Med; 2004 May; 23(5):615-22. PubMed ID: 15154527
    [TBL] [Abstract][Full Text] [Related]  

  • 69. A long follow-up on prostate specific antigen density and prostate biopsy.
    Netto Júnior NR; De Lima ML; Lavoura Júnior Nda S; Apuzzo F; De Lucena RG
    Arch Esp Urol; 1998 Dec; 51(10):1050-3. PubMed ID: 9951132
    [TBL] [Abstract][Full Text] [Related]  

  • 70. [Relationship between screening by stratifying cases into groups on prostate specific antigen level and the positive rate of transrectal ultrasound guided systematic sextant prostate biopsy].
    Cao XL; Gao JP; Han G; Tang J; Hong BF
    Zhonghua Wai Ke Za Zhi; 2006 Mar; 44(6):372-5. PubMed ID: 16638344
    [TBL] [Abstract][Full Text] [Related]  

  • 71. [Comparison of prostate volume measured by transrectal and abdominal echography and its implication for the measurement of the PSA density for the diagnosis of prostate cancer].
    Rodríguez-Patrón Rodríguez R; Mayayo Dehesa T; Lennie Zucharino A; González Galán A
    Arch Esp Urol; 2002 Sep; 55(7):797-806. PubMed ID: 12380308
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Prostate volume is strongest predictor of cancer diagnosis at transrectal ultrasound-guided prostate biopsy with prostate-specific antigen values between 2.0 and 9.0 ng/mL.
    Al-Azab R; Toi A; Lockwood G; Kulkarni GS; Fleshner N
    Urology; 2007 Jan; 69(1):103-7. PubMed ID: 17270628
    [TBL] [Abstract][Full Text] [Related]  

  • 73. The ratio of prostate-specific antigen (PSA) to prostate volume (PSA density) as a parameter to improve the detection of prostate carcinoma in PSA values in the range of < 4 ng/mL.
    Stephan C; Stroebel G; Heinau M; Lenz A; Roemer A; Lein M; Schnorr D; Loening SA; Jung K
    Cancer; 2005 Sep; 104(5):993-1003. PubMed ID: 16007682
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Determination of reference values for total PSA, F/T and PSAD according to prostatic volume in japanese prostate cancer patients with slightly elevated serum PSA levels.
    Kuriyama M; Uno H; Watanabe H; Yamanaka H; Saito Y; Shida K
    Jpn J Clin Oncol; 1999 Dec; 29(12):617-22. PubMed ID: 10721944
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Early detection of prostate cancer in the ESRD population.
    Khairullah QT; Pamatmat SD; Chatha M; Provenzano R; Telang D; Temple M
    Clin Nephrol; 2004 May; 61(5):308-15. PubMed ID: 15182125
    [TBL] [Abstract][Full Text] [Related]  

  • 76. [Parameters with possible influence in PSA adjusted for transition zone volume].
    Jara Rascón J; Subirá Ríos D; Lledó Garcia E; Martínez Salamanca JI; Moncada Iribarren I; Cabello Benavente R; Hernández Fernández C
    Actas Urol Esp; 2005 May; 29(5):473-80. PubMed ID: 16013792
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Early detection of prostate cancer in men with prostatism and intermediate prostate-specific antigen levels.
    Schmid HP; Ravery V; Billebaud T; Toublanc M; Boccon-Gibod LA; Hermieu JF; Delmas V; Boccon-Gibod L
    Urology; 1996 May; 47(5):699-703. PubMed ID: 8650868
    [TBL] [Abstract][Full Text] [Related]  

  • 78. [Early diagnosis of prostate carcinoma with reference to the density of prostate-specific antigen].
    Schmid HP; Ravery V; Toublanc M; Boccon-Gibod L
    Schweiz Med Wochenschr; 1996 Sep; 126(36):1530-5. PubMed ID: 8927956
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Evaluation of free-to-total prostate specific antigen (F/T PSA), prostate specific antigen density (PSAD) and (F/T)/PSAD sensitivity on reduction of unnecessary prostate biopsies for patients with PSA in gray zone.
    Milkovic B; Dzamic Z; Pejcic T; Kajmakovic B; Nikolic D; Cirovic D; Knezevic T; Dzamic D; Hadzi-Djokic J
    Ann Ital Chir; 2014; 85(5):448-53. PubMed ID: 25599711
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Evaluation of PSA-age volume score in predicting prostate cancer in Chinese population.
    Wu YS; Wu XB; Zhang N; Jiang GL; Yu Y; Tong SJ; Jiang HW; Mao SH; Na R; Ding Q
    Asian J Androl; 2018; 20(4):324-329. PubMed ID: 29405172
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.